Protalix BioTherapeutics
PLX
#8256
Rank
โ‚น21.45 B
Marketcap
โ‚น266.81
Share price
-0.34%
Change (1 day)
35.39%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): โ‚น1.74

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is โ‚น1.85. In 2024 the company made an earnings per share (EPS) of โ‚น3.69 a decrease over its 2023 EPS that were of โ‚น11.08.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น1.74-52.75%
2024โ‚น3.69-66.67%
2023โ‚น11.08-138.71%
2022-โ‚น28.62-50%
2021-โ‚น57.24181.82%
2020-โ‚น20.31-82.11%
2019-โ‚น113.56-31.67%
2018-โ‚น166.18-72.31%
2017-โ‚น600.10124.14%
2016-โ‚น267.74-147.54%
2015โ‚น563.17-290.63%
2014-โ‚น295.436.67%
2013-โ‚น276.97130.77%
2012-โ‚น120.02-69.77%
2011-โ‚น396.9919.44%
2010-โ‚น332.36-12.2%
2009-โ‚น378.5236.67%
2008-โ‚น276.97-37.5%
2007-โ‚น443.1550%
2006-โ‚น295.433.23%
2005-โ‚น286.20138.46%
2004-โ‚น120.02-74%
2003-โ‚น461.61-0%
2002-โ‚น461.61-50%
2001-โ‚น923.23233.33%
2000-โ‚น276.97-84.21%
1999-โ‚น1,754-24%
1998-โ‚น2,308-600%
1997โ‚น461.61-16.67%
1996โ‚น553.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น125.56 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น397.91 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น10.16-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น114.48 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel